New Drug Helps Patients With Atrial Fibrillation
The experimental anti-clotting drug apixaban beat aspirin at preventing dangerous clots or strokes in people with the abnormal heart rhythm atrial fibrillation, according to final results of the so-called AVERROES trial.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.
